Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam

Saved in:
Bibliographic Details
Published in:Thoracic Cancer
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868554007475126273
collection WordPress RSS
FRELIP Feed Integration
container_title Thoracic Cancer
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:93592
institution FRELIP
journal_source_facet Thoracic Cancer
last_indexed 2026-06-20T21:45:54.952Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
title_alt Alectinib versus ceritinib de primera línea con o sin radioterapia cerebral en cáncer de pulmón no microcítico ALK-positivo con metástasis cerebrales: Un estudio multicéntrico de mundo real desde Vietnam
Alectinib versus cérétinib en première ligne avec ou sans radiothérapie cérébrale dans le cancer du poumon non à petites cellules ALK-positif avec métastases cérébrales : une étude multicentrique en conditions réelles du Vietnam
Alectinibe de Primeira Linha versus Ceritinibe com ou sem Radioterapia Cerebral em Câncer de Pulmão de Células Não Pequenas ALK-Positivo com Metástases Cerebrais: Um Estudo Multicêntrico de Mundo Real do Vietnã
title_auth First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
title_es_txt Alectinib versus ceritinib de primera línea con o sin radioterapia cerebral en cáncer de pulmón no microcítico ALK-positivo con metástasis cerebrales: Un estudio multicéntrico de mundo real desde Vietnam
title_fr_txt Alectinib versus cérétinib en première ligne avec ou sans radiothérapie cérébrale dans le cancer du poumon non à petites cellules ALK-positif avec métastases cérébrales : une étude multicentrique en conditions réelles du Vietnam
title_full First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
title_fullStr First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
title_full_unstemmed First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
title_pt_txt Alectinibe de Primeira Linha versus Ceritinibe com ou sem Radioterapia Cerebral em Câncer de Pulmão de Células Não Pequenas ALK-Positivo com Metástases Cerebrais: Um Estudo Multicêntrico de Mundo Real do Vietnã
title_short First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
title_sort first‐line alectinib versus ceritinib with or without brain radiotherapy in alk‐positive non‐small cell lung cancer with brain metastases: a real‐world multicenter study from vietnam
topic Oncology
General
Oncology
url https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.70325?af=R